Logo image of ARBE

ARBE ROBOTICS LTD (ARBE) Stock Fundamental Analysis

NASDAQ:ARBE - Nasdaq - IL0011796625 - Common Stock - Currency: USD

2.75  +0.02 (+0.73%)

After market: 2.7103 -0.04 (-1.44%)

Fundamental Rating

2

Overall ARBE gets a fundamental rating of 2 out of 10. We evaluated ARBE against 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of ARBE have multiple concerns. ARBE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARBE had negative earnings in the past year.
In the past year ARBE has reported a negative cash flow from operations.
ARBE had negative earnings in each of the past 5 years.
In the past 5 years ARBE always reported negative operating cash flow.
ARBE Yearly Net Income VS EBIT VS OCF VS FCFARBE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

With a Return On Assets value of -106.75%, ARBE is not doing good in the industry: 95.00% of the companies in the same industry are doing better.
ARBE has a Return On Equity of -343.97%. This is amonst the worse of the industry: ARBE underperforms 95.83% of its industry peers.
Industry RankSector Rank
ROA -106.75%
ROE -343.97%
ROIC N/A
ROA(3y)-69.31%
ROA(5y)-141.24%
ROE(3y)-86.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARBE Yearly ROA, ROE, ROICARBE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 500 1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARBE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARBE Yearly Profit, Operating, Gross MarginsARBE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

More info and screens

1

2. Health

2.1 Basic Checks

ARBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARBE has more shares outstanding
There is no outstanding debt for ARBE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ARBE Yearly Shares OutstandingARBE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M
ARBE Yearly Total Debt VS Total AssetsARBE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ARBE has an Altman-Z score of -5.74. This is a bad value and indicates that ARBE is not financially healthy and even has some risk of bankruptcy.
ARBE has a Altman-Z score of -5.74. This is amonst the worse of the industry: ARBE underperforms 90.00% of its industry peers.
ARBE has a Debt/Equity ratio of 1.79. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.79, ARBE is doing worse than 92.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z -5.74
ROIC/WACCN/A
WACC9.11%
ARBE Yearly LT Debt VS Equity VS FCFARBE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

ARBE has a Current Ratio of 1.44. This is a normal value and indicates that ARBE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, ARBE is doing worse than 79.17% of the companies in the same industry.
ARBE has a Quick Ratio of 1.44. This is a normal value and indicates that ARBE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.44, ARBE is doing worse than 63.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.44
ARBE Yearly Current Assets VS Current LiabilitesARBE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

ARBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.58%, which is quite good.
The Revenue has decreased by -9.85% in the past year.
Measured over the past years, ARBE shows a very strong growth in Revenue. The Revenue has been growing by 64.54% on average per year.
EPS 1Y (TTM)15.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.56%
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y64.54%
Revenue growth 5YN/A
Sales Q2Q%-74.32%

3.2 Future

Based on estimates for the next years, ARBE will show a very strong growth in Earnings Per Share. The EPS will grow by 38.73% on average per year.
Based on estimates for the next years, ARBE will show a very strong growth in Revenue. The Revenue will grow by 103.56% on average per year.
EPS Next Y13.53%
EPS Next 2Y24.23%
EPS Next 3Y38.73%
EPS Next 5YN/A
Revenue Next Year-70.95%
Revenue Next 2Y19.96%
Revenue Next 3Y103.57%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ARBE Yearly Revenue VS EstimatesARBE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
ARBE Yearly EPS VS EstimatesARBE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ARBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARBE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARBE Price Earnings VS Forward Price EarningsARBE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARBE Per share dataARBE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as ARBE's earnings are expected to grow with 38.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.23%
EPS Next 3Y38.73%

More info and screens

0

5. Dividend

5.1 Amount

ARBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARBE ROBOTICS LTD

NASDAQ:ARBE (2/7/2025, 8:12:01 PM)

After market: 2.7103 -0.04 (-1.44%)

2.75

+0.02 (+0.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-27 2024-11-27/bmo
Earnings (Next)02-26 2025-02-26/amc
Inst Owners39.73%
Inst Owner Change-1.21%
Ins Owners10.22%
Ins Owner ChangeN/A
Market Cap233.94M
Analysts82.22
Price Target3.74 (36%)
Short Float %4.9%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.34%
Min EPS beat(2)-16.42%
Max EPS beat(2)13.75%
EPS beat(4)1
Avg EPS beat(4)-5.85%
Min EPS beat(4)-16.42%
Max EPS beat(4)13.75%
EPS beat(8)1
Avg EPS beat(8)-15.74%
EPS beat(12)2
Avg EPS beat(12)-22.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-19.02%
Min Revenue beat(2)-73.2%
Max Revenue beat(2)35.16%
Revenue beat(4)1
Avg Revenue beat(4)-47.07%
Min Revenue beat(4)-91.43%
Max Revenue beat(4)35.16%
Revenue beat(8)1
Avg Revenue beat(8)-46.5%
Revenue beat(12)1
Avg Revenue beat(12)-41.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.71%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-20%
Revenue NQ rev (3m)-29.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 202.9
P/FCF N/A
P/OCF N/A
P/B 13.59
P/tB 13.59
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.01
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -106.75%
ROE -343.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-69.31%
ROA(5y)-141.24%
ROE(3y)-86.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.25%
Cap/Sales 51.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.44
Altman-Z -5.74
F-Score2
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)155.26%
Cap/Depr(5y)126.24%
Cap/Sales(3y)25.91%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.56%
EPS Next Y13.53%
EPS Next 2Y24.23%
EPS Next 3Y38.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y64.54%
Revenue growth 5YN/A
Sales Q2Q%-74.32%
Revenue Next Year-70.95%
Revenue Next 2Y19.96%
Revenue Next 3Y103.57%
Revenue Next 5YN/A
EBIT growth 1Y-26.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.93%
EBIT Next 3Y32.83%
EBIT Next 5YN/A
FCF growth 1Y18.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.96%
OCF growth 3YN/A
OCF growth 5YN/A